Skip to main content
Caplight Logo









PlatinumRx

PlatinumRx

Private
BangaloreHealthcare & Life Scienceshttps://www.platinumrx.in/

Last Round

Series A

Sep 3, 2025

Total Funding Raised

$6.8M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

PlatinumRx is a healthcare company that operates an online pharmacy and tele-consultation platform providing affordable generic medicine substitutes to patients in India.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, E-commerce, Telemedicine

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

digital pharmacyonline pharmacye-pharmacypharmaceutical supply chainprescription deliverytelemedicinetele-consultationhealth-techmedicine delivery appdirect-to-patient distributionD2Ppharmacy marketplaceB2B2Conline medicine store

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PlatinumRx Comparables

Compare PlatinumRx with similar companies based on industry and business-model similarity.

PlatinumRx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tata Steel Limited
84%
Truemeds
77%
Pharmapick Services Private Limited
77%

PlatinumRx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 3, 2025
SeedApr 8, 2024

PlatinumRx Investors

Notable investors and investment history

PlatinumRx investors
InvestorRounds
India QuotientSeries A, Seed
Stellaris Venture PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Grew 33% QoQ, from 83 to 110 employees.

  • Jun 9, 2026

    Grew 34% QoQ, from 67 to 90 employees.

PlatinumRx Filings

Explore SEC and related filing metadata, where available.

PlatinumRx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PlatinumRx's valuation, stock price, and market status.

Is PlatinumRx a public or private company?

PlatinumRx is a private company.

What is the current stock price of PlatinumRx?

PlatinumRx is a private company with no public stock price. No recent secondary market data is available.

How much is PlatinumRx worth (valuation)?

Valuation information for PlatinumRx is not publicly available.

Can I buy PlatinumRx stock?

PlatinumRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PlatinumRx's last funding round?

PlatinumRx's most recent funding round was Series A on September 3, 2025.

Who are the main investors in PlatinumRx?

Key investors in PlatinumRx include India Quotient, Stellaris Venture Partners.

Will PlatinumRx IPO soon?

No public IPO plans have been announced for PlatinumRx.

How can I track PlatinumRx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PlatinumRx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBangalore
Employee Range115
Year Founded2023
Last FundingSep 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?